Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) Revenue (2016 - 2025)

Conmed (CNMD) has disclosed Revenue for 12 consecutive years, with $2.6 million as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Revenue changed N/A year-over-year to $2.6 million, compared with a TTM value of $2.6 million through Dec 2022, changed N/A, and an annual FY2025 reading of $1.4 billion, up 5.18% over the prior year.
  • Revenue was $2.6 million for Q1 2022 at Conmed, down from $252.8 million in the prior quarter.
  • Across five years, Revenue topped out at $264.9 million in Q4 2019 and bottomed at $2.6 million in Q1 2022.
  • Average Revenue over 4 years is $206.1 million, with a median of $218.4 million recorded in 2019.
  • The sharpest move saw Revenue increased 15.46% in 2019, then tumbled 33.78% in 2020.
  • Year by year, Revenue stood at $242.4 million in 2018, then increased by 9.25% to $264.9 million in 2019, then dropped by 4.54% to $252.8 million in 2020, then tumbled by 98.97% to $2.6 million in 2022.
  • Business Quant data shows Revenue for CNMD at $2.6 million in Q1 2022, $252.8 million in Q4 2020, and $237.8 million in Q3 2020.